Program_Memos / 2002 / AB-02-143

Why This Topic Matters

It helps facilities understand the scope of Medicare guidance described in the article and the kinds of clinical documentation and assessment topics emphasized for psychotropic drug use in SNFs.

Article Sections

1. Program Memorandum

   Administrative memorandum information from CMS, including transmittal details, dates, and implementation notices relevant to the attached educational article.

2. Psychotropic Drug Use in Skilled Nursing Facilities (SNF)

   Background discussion of psychotropic medication use in SNFs and the general issues addressed by the article.

3. Definition of an Unnecessary Drug

   General framework describing when a resident’s drug regimen is considered potentially problematic and the types of clinical factors referenced in the source.

4. Justification for Drug Use Outside Guidelines

   Types of documentation and assessment evidence discussed as support for medication use that does not fit routine expectations in the source article.

5. Guidelines for Use of Antipsychotic Drugs

   Overview of the article’s discussion of antipsychotic therapy in SNFs, including resident assessment, documentation, and review considerations.